Adaptive Biotechnologies
ADPT
#4171
Rank
HK$21.47 B
Marketcap
HK$140.68
Share price
0.00%
Change (1 day)
197.62%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: HK$21.47 Billion

As of January 2026 Adaptive Biotechnologies has a market cap of HK$21.47 Billion. This makes Adaptive Biotechnologies the world's 4171th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$21.47 B8.27%
2025HK$19.83 B175.26%
2024HK$7.20 B30.08%
2023HK$5.54 B-35.1%
2022HK$8.53 B-72.35%
2021HK$30.87 B-50.75%
2020HK$62.69 B114.83%
2019HK$29.18 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

HK$21.47 Billion
by Nasdaq info icon info icon
HK$21.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
HK$885.69 B 4,023.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
HK$18.22 B-15.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
HK$3.67 B-82.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
HK$14.81 B-31.03%๐Ÿ‡บ๐Ÿ‡ธ USA